Litcius/Paper detail

A skin-specific α-Synuclein seeding amplification assay for diagnosing Parkinson’s disease

Yaoyun Kuang, Hengxu Mao, Tingting Gan, Wenyuan Guo, Wei Dai, Weimeng Huang, Zhuohua Wu, Hongyan Li, Xiaoyun Huang, Xinling Yang, Pingyi Xu

2024npj Parkinson s Disease33 citationsDOIOpen Access PDF

Abstract

The seeding amplification assay (SAA) has recently emerged as a valuable tool for detecting α-synuclein (αSyn) aggregates in various clinically accessible biospecimens. Despite its efficiency and specificity, optimal tissue-specific conditions for distinguishing Parkinson's disease (PD) from non-PD outside the brain remain underexplored. This study systematically evaluated 150 reaction conditions to identify the one with the highest discriminatory potential between PD and non-synucleinopathy controls using skin samples, resulting in a modified SAA. The streamlined SAA achieved an overall sensitivity of 92.46% and specificity of 93.33% on biopsy skin samples from 332 PD patients and 285 controls within 24 h. Inter-laboratory reproducibility demonstrated a Cohen's kappa value of 0.87 (95% CI 0.69-1.00), indicating nearly perfect agreement. Additionally, αSyn seeds in the skin were stable at -80 °C but were vulnerable to short-term exposure to non-ultra-low temperatures and grinding. This study thoroughly investigated procedures for sample preprocessing, seed amplification, and storage, introducing a well-structured experimental framework for PD diagnosis using skin samples.

Topics & Concepts

Parkinson's diseaseSkin biopsyMedicinePathologyBiopsyDiseaseParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsAutism Spectrum Disorder Research
A skin-specific α-Synuclein seeding amplification assay for diagnosing Parkinson’s disease | Litcius